drug: thalidomide

• Clinical class: sedative hypnotic, antiangiogenesis, antinauseant, anti-leprosy, immunomodulatory
• Action: central nervous system depressant
• CSA schedule: none
• DEA number: none
• CDER thalidomide information
• MEDLINEplus^® Drug Information

U.S. Preparations:

• Thalomid^® (Celgene) FDA approved for treatment of:
  7.16.1998 erythema nodosa leprosum (leprosy, ENL)
  5.25.2006 newly diagnosed multiple myeloma in combination with dexametasone
  U.S. Prescribing Information

Preparations Outside U.S.:

• Kevadon^®, Synovir^®

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2009 BehaveNet®